Effective therapy of atopic dermatitis in children complicated by secondary infection
https://doi.org/10.21518/2079-701X-2016-1-162-167
Abstract
Atopic dermatitis (AtD) is one of chronic recurrent diseases. One of the most frequent complications of atopic dermatitis in children is secondary bacterial infection which plays a significant role in the pathogenesis of AtD and is a relevant factor for its aggravation. It is recurrent bacterial infection that often causes AtD refractory to standard therapy. Early effective etiotropic treatment of bacterial complications with baneocin is the key to achieving remission of AtD in children.
References
1. ELias PM, Schmuth M. Abnormal skin barrier in the etiopathogenesis of atopic dermatitis. Curr. Opin. Allrgy Clin. Immunol., 2009, 9(5): 437-46.
2. Hubiche T, Ged C, Benard A, Leaute-Labreze C et aL. Analysis of SPINK 5, KLK 7 and FLG genotypes in a French atopic dermatitis cohort. Acta Derm. Venerol,, 2007, 87(6): 499-05.
3. Kato A, Fukai K, Oiso N et aL. Association of SPINK5 gene polymorphisms with atopic dermatitis in the Japanese population. Br J Dermatol, 2003, 148: 665-69.
4. Leung D. Infection in atopic dermatitis. Curr Opin Pediatr, 2003, 15: 399-404.
5. ZoLLner ТМ, WicheLhaus TA, Hartung A et aL. CoLonization with superantigen producting StaphyLococcus aureus associated with increased severity of atopic dermatitis. Clin. Exp.Allergy, 2000, 30(7): 994-1000.
6. Petry V, Bessa GR, Poziomczyck CS et aL. BacteriaL skin coLonization and infections in patients with atopic dermatitis. An. Bras. Dermatol., 2012, 87: 729-34.
7. Lin YT, Hwang YW, Tsay MJ. Comparison of serum specific IgE-antibodies to staphyLococcaL entero-toxins between atopic chiLdren with and without atopic dermatitis. Allergy, 2000, 55(7): 641-46.
8. Leung D. Presence of IgE antibodies to staphy-LococcaL exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of aLLergens. J Clin Invest. 1993, 92: 1374-80.
9. Hauk P, Hamid OA, Chrousos GP, Leung D. Induction of corticosteroid insensitivity in human PBMCs by microbiaL superantygens. J Allergy Clin Immunol., 2000, 105 (4): 782-87.
10. Boguniewicz M, Schmid-GrendeLmeier P, Leung D. Atopic dermatitis. J Allergy Clin Immunol. 2006, 118: 40-43.
11. Ларькова ИА. Рациональная наружная терапия атопического дерматита у детей: в помощь практическому врачу. Consilium medicum, (педиатрия, приложение), 2008, 2: 53-7.
12. Паршина В.Л. Профилактика и лечение гнойно-септических заболеваний кожи, подкожной клетчатки и пупочной ранки в практике неонатальной реанимации. Consilium Medicum (педиатрия), 2007, 1(9): 13-17.
13. Короткий Н.Г., Шарова Н.М., Сидоренко ОА. Банеоцин в терапии осложненных форм атопического дерматита. Клин. дерм. и вен, 2006, 1: 97-100.
14. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta DermVenerol, 1980, 92: 44-47.
15. Larkova I.A. Rational topical anti-inflammatory therapy of atopic dermatitis in children: to help the practitioner. Consilium medicum (Pediatrics supplement), 2008, 2: 53-7.
16. Parshina V.L. Prevention and treatment of septic diseases of the skin, subcutaneous tissue and umbilical wound in practical neonatal resuscitation. Consilium Medicum (Pediatrics), 2007, 1(9): 13-17.
17. Korotkiy N.G., Sharova N.M., Sidorenko O.A. Baneocin in the treatment of complicated atopic dermatitis. Klin. Derm. i Ven., 2006, 1: 97-100.
Review
For citations:
Larkova IA. Effective therapy of atopic dermatitis in children complicated by secondary infection. Meditsinskiy sovet = Medical Council. 2016;1(1):162-167. (In Russ.) https://doi.org/10.21518/2079-701X-2016-1-162-167
Views:
822
Email this article 